A number of GlycoPols™, comprising chain lengths of between 6 and 100 units and several different mono- and di-saccharides, have been evaluated for binding to twenty-five normal and inflamed human tissues. The GlycoPols™ show specific and selective binding, together with various degrees of tissue specificity, indicating these novel polymers can be used to target ‘cargos’ to tissues.
Binding of biotin-labelled GlycoPols™ to normal human breast, colon and prostate tissues
